Intra-Cellular Therapies to Present at Two Upcoming May 2023 Investor Conferences

NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at two upcoming investor conferences:

Bank Of America Securities 2023 Health Care Conference
Tuesday, May 9, 2023 at 2:20 p.m. PT. (5:20 p.m. ET.)

2023 RBC Capital Markets Global Healthcare Conference
Wednesday, May 17, 2023 at 10:30 a.m. ET.

A live and achieved webcast of the presentations can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations

Burns McClellan, Inc.
Cameron Radinovic

Primary Logo

Back to news